We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
GenoLogics Announces Availability of Clarity LIMS 3.1
News

GenoLogics Announces Availability of Clarity LIMS 3.1

GenoLogics Announces Availability of Clarity LIMS 3.1
News

GenoLogics Announces Availability of Clarity LIMS 3.1

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "GenoLogics Announces Availability of Clarity LIMS 3.1"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

GenoLogics Life Sciences Software has announced the availability of Clarity LIMS 3.1. In addition to providing support for HIPAA-covered entities, Clarity LIMS extends its toolset for labs working with patient populations with features that support clinical compliance.

Version 3.1 further supports the needs of these labs with electronic signatures, configurable permissions, and detailed audit trail reporting.

To help labs conduct operations electronically, regulating agencies, such as the FDA, have published standards-21 CFR Part 11 is one-that describe how electronic approvals or signatures should be recorded.

Clarity LIMS is designed to this standard and allows labs to configure electronic signature requirements, without developer intervention, which supports compliance yet speeds implementation. Furthermore, Clarity LIMS prevents processes that are missing required approvals from moving forward.

21 CFR Part 11 also requires that systems restrict functionality to users with appropriate permissions to prevent error, data loss, or tampering. Clarity LIMS meets this requirement with configurable role-based permissions, preventing access where not needed.

Adding to this security is the system’s ability to produce a human readable audit trail that details all system events, who performed the events, and when. A record of the previously recorded data is also kept if the event involved a change to data.

“We are proud to release version 3.1 of Clarity LIMS and further support compliance requirements,” states Michael Ball, CEO of GenoLogics. Ball adds, “These features reiterate our dedication to make next generation sequencing a mainstay in clinical environments.”

Advertisement